BR9608837A - "composition obtained from cells to detect an infection by human immunodeficiency virus, apparatus, kit and methods for its detection, purification of protein and obtaining and treating human beings" - Google Patents
"composition obtained from cells to detect an infection by human immunodeficiency virus, apparatus, kit and methods for its detection, purification of protein and obtaining and treating human beings"Info
- Publication number
- BR9608837A BR9608837A BR9608837-0A BR9608837A BR9608837A BR 9608837 A BR9608837 A BR 9608837A BR 9608837 A BR9608837 A BR 9608837A BR 9608837 A BR9608837 A BR 9608837A
- Authority
- BR
- Brazil
- Prior art keywords
- cells
- immunodeficiency virus
- methods
- infection
- kit
- Prior art date
Links
- 241000725303 Human immunodeficiency virus Species 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 4
- 208000015181 infectious disease Diseases 0.000 title abstract 3
- 241000282414 Homo sapiens Species 0.000 title abstract 2
- 238000001514 detection method Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 238000000746 purification Methods 0.000 title 1
- 208000030507 AIDS Diseases 0.000 abstract 3
- 229960005486 vaccine Drugs 0.000 abstract 2
- 238000003745 diagnosis Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000001742 protein purification Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 210000001541 thymus gland Anatomy 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Computational Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Toxicology (AREA)
- Oncology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
Abstract
<B>"COMPOSIçãO OBTIDA DE CéLULAS PARA DETECTAR UMA INFECçãO POR VìRUS DA IMUNODEFICIêNCIA HUMANA, APARELHO, KIT E MéTODOS PARA SUA DETECçãO, PURIFICAçãO DA PROTEìNA E SUA OBTENçãO E TRATAMENTO DO SER HUMANO"<D>. Esta invenção refere-se à área de imunologia e virologia; e especificamente refere-se a composições obtidas de células de timo de mamíferos as quais são úteis como diagnósticos, vacinas e terapêuticos para infecções por vírus da imunodeficiência humana (HIV) e doenças relacionadas, tais como síndrome da imunodeficiência adquirida (AIDS) e complexo relacionado à AIDS (ARC), o diagnóstico, a vacina e métodos terapêuticos, bem como aparelhos utilizando estas composições, são também revelados.<B> "COMPOSITION OBTAINED FROM CELLS TO DETECT AN INFECTION BY HUMAN IMMUNODEFICIENCY VIRUS, APPARATUS, KIT AND METHODS FOR THEIR DETECTION, PROTEIN PURIFICATION AND THEIR OBTAINING AND TREATMENT OF THE HUMAN BEING" <D>. This invention relates to the field of immunology and virology; and specifically refers to compositions obtained from mammalian thymus cells which are useful as diagnostics, vaccines and therapeutics for human immunodeficiency virus (HIV) infections and related diseases, such as acquired immunodeficiency syndrome (AIDS) and related complex AIDS (ARC), diagnosis, vaccine and therapeutic methods, as well as devices using these compositions, are also revealed.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43188395A | 1995-05-01 | 1995-05-01 | |
US48554895A | 1995-06-07 | 1995-06-07 | |
PCT/US1996/006079 WO1996034886A1 (en) | 1995-05-01 | 1996-05-01 | Compositions and methods for detecting and treating acquired immunodeficiency syndrome |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9608837A true BR9608837A (en) | 1999-12-07 |
Family
ID=27029254
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9608837-0A BR9608837A (en) | 1995-05-01 | 1996-05-01 | "composition obtained from cells to detect an infection by human immunodeficiency virus, apparatus, kit and methods for its detection, purification of protein and obtaining and treating human beings" |
Country Status (6)
Country | Link |
---|---|
JP (1) | JP3816524B2 (en) |
AR (1) | AR001840A1 (en) |
AU (1) | AU721463B2 (en) |
BR (1) | BR9608837A (en) |
NZ (1) | NZ308708A (en) |
WO (1) | WO1996034886A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2215108A4 (en) | 2007-10-23 | 2012-07-04 | Univ Colorado | Competitive inhibitors of invariant chain expression and/or ectopic clip binding |
AU2009274568A1 (en) * | 2008-07-25 | 2010-01-28 | The Regents Of The University Of Colorado | Proteins for use in diagnosing and treating infection and disease |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4415553A (en) * | 1973-08-06 | 1983-11-15 | Dso "Pharmachim" | Compositions, processes for their preparation and method for treatment of neoplasms |
WO1985003003A1 (en) * | 1984-01-12 | 1985-07-18 | Volker Rusch | Biologically active substance with hormonal properties, production process thereof and utilization of histones for medical purposes |
WO1989005455A1 (en) * | 1987-12-02 | 1989-06-15 | The Regents Of The University Of California | Aids-related anti-t-cell antibody test |
GB9209874D0 (en) * | 1992-05-07 | 1992-06-24 | Ml Lab Plc | Pharmaceutical compositions |
-
1996
- 1996-05-01 AU AU58519/96A patent/AU721463B2/en not_active Ceased
- 1996-05-01 NZ NZ308708A patent/NZ308708A/en unknown
- 1996-05-01 BR BR9608837-0A patent/BR9608837A/en not_active IP Right Cessation
- 1996-05-01 WO PCT/US1996/006079 patent/WO1996034886A1/en active IP Right Grant
- 1996-05-01 JP JP53345796A patent/JP3816524B2/en not_active Expired - Fee Related
- 1996-05-02 AR AR33638296A patent/AR001840A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU721463B2 (en) | 2000-07-06 |
NZ308708A (en) | 1998-11-25 |
AR001840A1 (en) | 1997-12-10 |
JP3816524B2 (en) | 2006-08-30 |
AU5851996A (en) | 1996-11-21 |
WO1996034886A1 (en) | 1996-11-07 |
JP2002504885A (en) | 2002-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1106207T1 (en) | ANTIINIC NUCLEOSITE DERIVATIVES | |
CY1108578T1 (en) | PHARMACEUTICAL COMPOSITIONS (KITS) INCLUDING DIHYDROPYRIDINONES COMPOUNDS AND AN IMMUNE REGULATORY (OR ANTI-FLUID INFECTION) | |
BR9708114A (en) | Xanthone analogues for the treatment of infectious diseases. | |
EA199901031A1 (en) | Derivatives of benzimidazole | |
TR199802537T2 (en) | Peptide tèrevleri. | |
EA200100302A1 (en) | METHODS AND COMPOSITIONS FOR PROTECTIVE AND THERAPEUTIC GENETIC IMMUNIZATION | |
BR0012919A (en) | Vaccine for use in the prophylaxis and / or treatment of white spot syndrome in crustaceans, structural protein derived from white point syndrome virus, nucleic acid sequence, use of a structural protein, pharmaceutical composition, antibodies, vaccine or pharmaceutical formulation, and, diagnostic kit for wssv detection | |
NO971625L (en) | Novel peptides with immunomodulatory effects | |
TR199801614T2 (en) | Peptide derivatives | |
AR003941A1 (en) | HIV-1 NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES | |
BR9608837A (en) | "composition obtained from cells to detect an infection by human immunodeficiency virus, apparatus, kit and methods for its detection, purification of protein and obtaining and treating human beings" | |
BR9707142A (en) | Purified polynucleotide, dna, vector, host cell, hybridoma cell line, monoclonal antibody, processes to produce exodus, to increase resistance to infection by human immunodeficiency virus (hiv), for treatment of human immunodeficiency virus (hiv) infection , for the protection of bone marrow progenitor cells against cytotoxic effects and for the treatment of myeloproliferative diseases, and the use of an exodus protein product. | |
ES2057579T3 (en) | PEPTIDES E1 AND C OF RUBEOLA. | |
EA200500533A1 (en) | PEPTIDE DERIVATIVES - MERCURY INHIBITORS IN HIV INFECTION | |
NO980300L (en) | New high molecular weight human MP52 proteins | |
DE69615015D1 (en) | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING THE ACQUIRED IMMUNE DEFICIENCY SYNDROME | |
BR0209892A (en) | Method of preparing a compound, compound, pharmaceutical composition, use of a compound, and method of treating a patient suffering from an hppar alpha mediated disease or condition | |
DE69726743D1 (en) | PEPTID ANALOGS CONTAINING A SEVEN LACTAMRING | |
ES2152285T3 (en) | PHARMACEUTICAL PREPARATION BASED ON THE CLARA CC10 CELL PROTEIN AND ITS USE AS A MEDICINAL PRODUCT AND IN DIAGNOSIS. | |
FR2694938B1 (en) | NOVEL PEPTIDES, ANTIBODIES DIRECTED AGAINST SUCH PEPTIDES, ANTI-IDIOTYPIC ANTIBODIES, APPLICATION AS DRUGS, PHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC KITS CONTAINING THEM. | |
ATE183652T1 (en) | SYNTHETIC PEPTIDES FOR THE TREATMENT OF MYASTHENIA GRAVIS | |
UA42693C2 (en) | The medicine for treating the infection by lentivirus, the preparation for human treatment which is infected by lentivirus. | |
SE8206128D0 (en) | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF NURSTONES Caused By Infection | |
BRPI0417798A (en) | 72 kda outer membrane protein of brachyspira pilosicoli and its diagnostic and therapeutic uses | |
EP0491888A4 (en) | Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EG | Technical examination (opinion): publication of technical examination (opinion) | ||
FB36 | Technical and formal requirements: requirement - article 36 of industrial property law | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] | ||
B24C | Patent annual fee: request for for restoration |
Free format text: REFERENTE A 13A,14A E 15A ANUIDADE(S). |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE AO DESPACHO 24.3 NA RPI 2113 DE 05/07/2011, E COMPROVAR O RECOLHIMENTO DA 12A,16A E 17A ANUIDADE. |